4-113903236-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024590.4(ARSJ):āc.838G>Cā(p.Glu280Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024590.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSJ | ENST00000315366.8 | c.838G>C | p.Glu280Gln | missense_variant | 2/2 | 1 | NM_024590.4 | ENSP00000320219.7 | ||
ARSJ | ENST00000509829.1 | n.*517G>C | non_coding_transcript_exon_variant | 4/4 | 1 | ENSP00000421327.1 | ||||
ARSJ | ENST00000509829.1 | n.*517G>C | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000421327.1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000721 AC: 18AN: 249526Hom.: 0 AF XY: 0.0000813 AC XY: 11AN XY: 135370
GnomAD4 exome AF: 0.000149 AC: 218AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.000146 AC XY: 106AN XY: 727232
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.838G>C (p.E280Q) alteration is located in exon 2 (coding exon 2) of the ARSJ gene. This alteration results from a G to C substitution at nucleotide position 838, causing the glutamic acid (E) at amino acid position 280 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at